OBJECTIVES: Evaluate from the patient perspective a systemic anti-cancer therapy homecare service METHODS: A pilot project was undertaken at the Royal Surrey County Hospital, in England, where three oral anti-cancer drugs were prescribed by hospital clinicians but dispensed by a homecare company. Patients were asked at the point of recruitment by the oncology pharmacists at the Royal Surrey County Hospital whether they were willing to take part in the homecare project. A questionnaire was developed with the input of patients. The questionnaire was tested with five patients for acceptability and their comments fed into the design of the final questionnaire. The questionnaire consisted of open and closed questions and was sent out by the homecare company to all patients who were receiving homecare six months after the start of the project. The questionnaire was returned to the Cancer Network Pharmacist for analysis. RESULTS: Ninety-one patients were approached to take part in the project by the  oncology pharmacy staff at the Royal Surrey County Hospital. When first approached 78 patients were prepared to take part in project, some declined and others required time to decide. The questionnaire was sent out to 85 patients. A total of 49 questionnaires were returned but some were not included in the analysis as they were from deceased patients or had been completed by a carer. Of the 40 questionnaires analysed 34 patients were willing to continue to receive their medication via homecare, 18 specifically stated a benefit was not waiting at the hospital for their medicine and 4 patients specifically stated they preferred to receive their medicines via homecare than from a community pharmacy. CONCLUSIONS: Patients find homecare acceptable for the delivery of systemic anti-cancer therapy and some prefer it to waiting at hospital for their medication or going to a community pharmacy to have their prescription dispensed.